Figure 1 presents a box plot of the CD24/CD11b levels in healthy subjects versus subjects with benign cancer. Flow cytometry analysis showed levels of CD24/CD11b expression in PBLs obtained from the study participants. The average level of CD24/CD11b in healthy patients (22.8 ± 9.3) was significantly lower compared to the that of the subjects with benign tumors (26.1 ± 10.5, p<0.001). Benign tumor type distribution is attached as Supplementary Table S1. This evidence concerns the gene CD24 and benign neoplasm.